Authors suggested possible unique infection mechanisms that might be hindered in smokers, such as an anti-inflammatory mechanism mediated by nicotinic acetylcholine receptor in COVID-19 pathology or angiotensin converting enzyme 2 expression in tissues. This evidence concerns the gene ACE2 and COVID-19.